In conclusion, this study suggests that c-MET expression is a significant risk factor in ESCC; elevated c-MET levels are associated with poor survival outcomes, later clinical stages and increased distant metastasis. The gene discussed is MET; the disease is esophageal squamous cell carcinoma.